
Stem cells and exosomes against DIC syndrome
November, 16 2024
A study in the International Journal of Nanomedicine reveals the potential of mesenchymal stem cells (MSC) and their exosomes in the therapy of DIC (disseminated intravascular coagulation), a dangerous condition with uncontrolled thrombosis.
A study in the International Journal of Nanomedicine reveals the potential of mesenchymal stem cells (MSC) and their exosomes in the therapy of DIC (disseminated intravascular coagulation), a dangerous condition with uncontrolled thrombosis.